Epratuzumab, CAS 205923-57-5

Product Description: Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Carnahan J, et al. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3982S-90S.

CAS Number: 205923-57-5

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: CD22

• Artikelnummer: MEXHY-P99289-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99289-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK